Vanguard Group Inc Lantern Pharma Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 363,720 shares of LTRN stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
363,720
Previous 363,720
-0.0%
Holding current value
$1.24 Million
Previous $1.7 Million
21.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LTRN
# of Institutions
34Shares Held
1.31MCall Options Held
39.8KPut Options Held
6.1K-
Cm Management, LLC185KShares$632,7000.57% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$469,6950.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$299,0270.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$287,2800.0% of portfolio
-
Davenport & CO LLC53.8KShares$184,0430.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $37M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...